Modelled DT Structure
Method: multi-sequence alignment based machine learning
Detail: Structure Info
General Information of DT | |||||
---|---|---|---|---|---|
DT ID | DTD0330 | ||||
Gene Name | SLC38A3 | ||||
Protein Name | Sodium-coupled neutral amino acid transporter 3 | ||||
Gene ID | |||||
UniProt ID | |||||
TCDB ID | |||||
3D Structure |
Modelled DT Structure Method: multi-sequence alignment based machine learning Detail: Structure Info |
||||
Synonyms | G17; Na(+)-coupled neutral amino acid transporter 3; SLC38A3; SN1; SNAT3; Solute carrier family 38 member 3 | ||||
DT Family | Amino Acid/Auxin Permease (AAAP) Family ; | ||||
Function | This transporter mediates electrogenic cotransport of glutamine and sodium ions in exchange for protons. Also recognizes histidine, asparagine and alanine. May mediate amino acid transport in either direction under physiological conditions. May play a role in nitrogen metabolism and synaptic transmission. | ||||
Disease(s) | Short bowel syndrome [ICD-11: KB89.1] | ||||
Vitamin deficiency [ICD-11: 5B55-5B7Z] | |||||
Bed wetting [ICD-11: MF50.2Y] | |||||
Endogenous Substrate(s) | Asparagine; H+; Na+ | ||||
Variability Data of This Drug Transporter (DT) | |||||
Regulatory Variability Data of This DT (VARIDT 3.0) |
|||||
(α) Microbiota Influence of This DT |
|||||
(β) Post-translational Modification of This DT |
|||||
(γ) Transcriptional Regulation of This DT |
|||||
(δ) Epigenetic Regulation of This DT |
|||||
(ε) Exogenous Modulation of This DT |
|||||
Structural Variability Data of This DT (VARIDT 2.0) |
|||||
(β) Inter-species Structural Differences |
|||||
General Variability Data of This DT (VARIDT 1.0) |
|||||
(β) Disease-specific Protein Abundances of This DT |
|||||
(γ) Species- and Tissue-specific DT Abundances |
|||||
Molecular Transporting Profile of This DT | |||||
Full List of Drug(s) Transported by This DT |
|||||
Approved Drug |
Click to Show/Hide the Full List of Drug: 4 Drugs in Total | ||||
Drug Name | Highest Status | Detail | Indication | ICD 11 | Ref |
Aminosalicylic acid
|
Approved | Drug Info | Bed wetting | MF50.2Y | [1] |
Folic acid
|
Approved | Drug Info | Vitamin deficiency | 5B55-5B7Z | [2] |
L-alanine
|
Approved | Drug Info | Glioma | 2A00.0 | [3] |
L-glutamine
|
Approved | Drug Info | Short bowel syndrome | KB89.1 | [3] |
References | |||||
1 | Identification of amino acids imparting acceptor substrate selectivity to human arylamine acetyltransferases NAT1 and NAT2. Biochem J. 2000 May 15;348 Pt 1:159-66. | ||||
2 | Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E. coli and characterization of its potential role in folate metabolism. Biochem Pharmacol. 1995 Jun 16;49(12):1759-67. | ||||
3 | Identification of SLC38A7 (SNAT7) protein as a glutamine transporter expressed in neurons. J Biol Chem. 2011 Jun 10;286(23):20500-11. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.